Segment Information (Tables)

3 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Segment

	Three months ended March 31,
Sale of Product	2018		2017 (as adjusted)
Radiochemical Products	$	583,541	$	613,580
Cobalt Products		327,778		219,423
Nuclear Medicine Standards		1,002,113		808,406
Radiological Services		887,594		192,799
Fluorine Products		-		-
Total Segments		2,801,026		1,834,208
Corporate revenue		-		-
Total Consolidated	$	2,801,026	$	1,834,208
	Three months ended March 31,
Depreciation and Amortization	2018		2017 (as adjusted)
Radiochemical Products	$	5,014	$	1,609
Cobalt Products		4,043		9,770
Nuclear Medicine Standards		17,938		2,145
Radiological Services		12,039		12,438
Fluorine Products		26,095		26,095
Total Segments		65,130		52,057
Corporate depreciation and amortization		4,844		3,528
Total Consolidated	$	69,974	$	55,585
	Three months ended March 31,
Segment Income (Loss)	2018		2017 (as adjusted)
Radiochemical Products	$	40,520	$	118,155
Cobalt Products		184,792		120,061
Nuclear Medicine Standards		223,942		183,972
Radiological Services		402,012		90,918
Fluorine Products		(31,299)		(84,878)
Total Segments		819,966		428,228
Corporate loss		(785,562)		(1,214,494)
Net Income	$	34,404	$	(786,266)
	Three months ended March 31,
Expenditures for Segment Assets	2018		2017 (as adjusted)
Radiochemical Products	$	-	$	-
Cobalt Products		-		-
Nuclear Medicine Standards		18,148		(198)
Radiological Services		-		-
Fluorine Products		1,560		4,172
Total Segments		19,708		3,974
Corporate purchases		-		-
Total Consolidated	$	19,708	$	3,974
	March 31,		December 31,
Segment Assets	2018		2017 (as adjusted)
Radiochemical Products	$	320,491	$	282,971
Cobalt Products		2,291,891		1,813,356
Nuclear Medicine Standards		1,960,824		2,214,061
Radiological Services		150,173		198,437
Fluorine Products		5,675,321		5,702,159
Total Segments		10,398,700		10,210,984
Corporate assets		2,433,947		1,794,310
Total Consolidated	$	12,832,647	$	12,005,294